Midland, MI, United States of America

Timothy Charles Frank

This inventor holds 20 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 12 EPO patents. Top assignees: Dow Global Technolgoies LLC, Dow Agrosciences LLC, Cargill Inc.. Active years: 1989-2018.

USPTO Granted Patents = 20 

% Patents Active = 45.0

 

 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 1989-2018

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: The Innovative Journey of Timothy Charles Frank

Introduction: Timothy Charles Frank, a visionary inventor hailing from Midland, MI, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Timothy Charles Frank's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time, and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a career spanning over two decades, Timothy Charles Frank has established himself as a pioneer in the tech world. His innovative spirit and dedication to creating impactful solutions have led to numerous successful ventures and patents.

Collaborations: Throughout his career, Timothy Charles Frank has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has resulted in the development of groundbreaking technologies.

Conclusion: Timothy Charles Frank's passion for innovation and his relentless drive to push the boundaries of technology have solidified his position as a respected inventor in the industry. His contributions continue to inspire future generations of inventors to think outside the box and create a positive impact on the world.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…